Wiktor Szymaski participant in KWF Research and Implementation grant
A KWF grant of 700k Eur was awarded to Bart Cornelissen (UMCG, main applicant) and Wiktor Szymanski (co applicant) for developing new medicines that can be activated with X-ray irradiation. This type of irradiation is typically used in cancer radiotherapy, where it can be precisely delivered to the tumors and damage DNA in their cells, leading to a therapeutic effect. In this project, Wiktor and Bart will combine this effect with pharmacotherapy, and use the same irradiation to also locally activate a chemotherapeutic drug for a synergistic action. Wiktor will be responsible for the chemistry part, developing new, efficient ways in which molecules can be selectively activated by photons of high energy, which can also be used in other therapeutic applications.
Original KWF announcement "Plaatselijke behandeling met stralingsgevoelige medicijnen"
| Last modified: | 17 July 2023 10.00 a.m. |
More news
-
16 April 2024
UG signs Barcelona Declaration on Open Research Information
In a significant stride toward advancing responsible research assessment and open science, the University of Groningen has officially signed the Barcelona Declaration on Open Research Information.
-
02 April 2024
Flying on wood dust
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
-
18 March 2024
VentureLab North helps researchers to develop succesful startups
It has happened to many researchers. While working, you suddenly ask yourself: would this not be incredibly useful for people outside of my own research discipline? There are many ways to share the results of your research. For example, think of a...